Why pre-screen bioinformatics analysts before the analysis take-home and panel interview
Pre-screening bioinformatics analysts protects the panel from candidates whose skills stop at running someone else's Nextflow workflow. Applicants arrive from PhD programmes, core facilities, and self-taught data science routes, and every resume lists Python, R, and RNA-seq. What it cannot show is whether they chose the statistical model, understood the library prep, or ever reran an analysis a year later and got the same numbers. Ten minutes surfaces version pinning habits, batch effect awareness, and whether they can explain a result to a bench scientist.
What actually matters when screening Bioinformatics Analyst candidates
- 01
Technical proficiency
Probe both sides: the biology behind the assay and the tooling and statistics used to analyse it.
- 02
Systems and trade-offs
Test how they build pipelines that survive rerunning: reproducibility, versioning, and compute cost at real sample counts.
- 03
Evidence and rigour
Check how they guard against batch effects, multiple testing, and a result that is too good to be true.
- 04
Collaboration and communication
Assess how they hand findings to wet-lab scientists or clinicians who will design the next experiment on them.
Pre-screening questions to ask Bioinformatics Analyst candidates
12 questions grouped by what they test. Ask the same set in every screen and score answers on a consistent scale, or send them as an async video screen and compare answers side by side.
Assay and tooling depth
Which sequencing technologies have you worked with, and how did each one change your analysis approach?
Names platforms such as Illumina short read, PacBio HiFi, Oxford Nanopore, or 10x single cell, and links read length and error profile to aligner and caller choices.
Lists platform names without saying what changed downstream, or treats all sequencing data as interchangeable FASTQ files.
Which programming languages do you use most for bioinformatics work, and what do you reach for each one to do?
Splits the work concretely: R with Bioconductor for statistics and plots, Python for data wrangling, Bash for glue, plus a workflow language such as Nextflow.
Claims fluency in five languages but cannot say which one they used for their most recent analysis or why.
Which bioinformatics tools and software are you genuinely comfortable running end to end?
Names specific tools and versions (BWA-MEM, STAR, minimap2, GATK, samtools, Salmon, Seurat) and explains a parameter they deliberately changed from default.
Recites a tool list from a course syllabus with no parameters, no versions, and no sense of when a tool is the wrong choice.
Talk me through the statistical methods you have used in genomics, and how you chose them.
Explains count-based models such as DESeq2 or limma-voom, covariate handling, FDR control, and how sample size shaped what they could claim.
Applies a t-test to count data or cannot explain the difference between a raw p-value and an adjusted one.
Pipelines and scale
How do you ensure another analyst could rerun your analysis a year from now and get the same numbers?
Cites a workflow manager, Docker or Singularity containers, pinned environments, git commits, recorded reference build, and fixed seeds as standard practice.
Relies on memory, a shared drive, or a Jupyter notebook with cells run out of order and no environment record.
How do you manage large datasets when sample counts and storage costs start to bite?
Talks about real numbers: terabytes, CRAM over BAM, chunking, SLURM or cloud batch jobs, spot instances, caching intermediate steps, and cost per sample.
Has only ever analysed toy datasets on a laptop and has no view on compute or storage cost.
Tell me about a time you had to troubleshoot a bioinformatics pipeline that broke or gave wrong output.
A specific failure with diagnosis: out-of-memory exit codes, a mismatched annotation GTF, a silent sample swap, and what they changed to stop it recurring.
Blames the cluster or a collaborator and describes no logs, no root cause, and no preventive fix.
Rigour and validation
How would you validate the results of a bioinformatics analysis before anyone acts on them?
Names orthogonal checks: qPCR or a second assay, a held-out cohort, positive and negative controls, permutation tests, and sanity checks against known biology.
Treats a significant adjusted p-value or a pretty heatmap as validation in itself.
Walk me through how you clean and preprocess raw data, and how you decide what to exclude.
Describes FastQC and MultiQC review, adapter and quality trimming, duplicate rates, sex and identity checks, and QC thresholds set before seeing results.
Drops samples until the effect appears, or cannot name a single QC metric they act on.
Handoff and ways of working
How do you communicate complex bioinformatics findings to wet-lab scientists or clinicians who will design the next experiment?
Frames results in biological terms with effect sizes, states caveats and confidence, and suggests the specific follow-up experiment or validation target.
Hands over a spreadsheet of significant genes with no interpretation, caveats, or recommended next step.
Share one figure you built from complex biological data and spend 60 seconds explaining what it shows and who it was for.
A real figure (PCA, volcano, UMAP, coverage track) with labelled axes, stated thresholds, and a clear account of the decision it informed.
Shows an unlabelled default plot or cannot say what question the figure was answering.
How do you like to work with a project team, and what access and cadence do you need to be productive here?
Concrete practices: git branches and code review, shared issue tracking, regular meetings with bench scientists, plus clear needs on cluster or cloud access and time zone overlap.
Works alone on a local machine, avoids code review, and has no interest in the experimental design side.
How to score responses
Score every candidate on the same four criteria immediately after the screen. At this stage you are shortlisting for panel interviews, not making the final call.
| Criterion | What a 5 looks like | Scale |
|---|---|---|
| Technical proficiency | Fluent in both the assay biology and the analysis stack, and can explain what each tool assumes. | 1 · 2 · 3 · 4 · 5 |
| Systems and trade-offs | Builds reproducible, versioned pipelines that rerun cleanly at real sample scale, with cost understood. | 1 · 2 · 3 · 4 · 5 |
| Evidence and rigour | Guards rigorously against batch effects and multiple testing, and can name a result they disproved themselves. | 1 · 2 · 3 · 4 · 5 |
| Collaboration and communication | Explains findings and their limits so lab scientists or clinicians can act on them without overreading. | 1 · 2 · 3 · 4 · 5 |
Async video lets you watch a candidate walk through their own volcano plot or QC report on screen, which is the fastest way to tell whether they can explain an FDR cutoff to a bench scientist rather than just compute one.
Try it on HirevireScreening FAQ
Process basics
How long should a bioinformatics analyst pre-screen be?
Keep it to eight to twelve minutes of recorded answers across roughly ten questions. That is enough for one assay-specific question, one pipeline and reproducibility question, one statistics question, and one communication ask. Save the take-home analysis of a real count matrix or FASTQ subset for candidates who clear the screen, since it costs both sides hours.
Should I screen for Python and R, or for biology knowledge?
Screen for both, because the failure modes differ. Strong coders with no assay knowledge miss sample swaps, adapter contamination, and impossible effect sizes; strong biologists without engineering habits produce analyses nobody can rerun. Ask one question anchored in library prep or sequencing chemistry and one anchored in Snakemake, containers, or version control, then compare depth.
Evaluating answers
What does a strong answer about reproducibility actually contain?
A strong answer names specific mechanisms, not intentions. Listen for a workflow manager (Nextflow, Snakemake, WDL), containers or pinned conda environments, git-tracked analysis code, a recorded reference genome build such as GRCh38, tool versions in the methods, and fixed random seeds. Vague answers about tidy folders and good documentation are not reproducibility.
How do I spot a bioinformatics analyst who accepts false positives?
Ask how they reacted to a result that looked too good, and listen for skepticism with a method attached. Good answers mention multiple testing correction (Benjamini-Hochberg FDR), checking whether the signal tracks a batch, sequencing date or sex, permutation tests, and orthogonal validation by qPCR or a held-out cohort. Weak answers celebrate the p-value.
























